KEY TAKEWAYS Structured cognitive assessments are an important tool in the detection and diagnosis of early Alzheimer’s disease. Most older adults are aware of cognitive assessment screenings and most report … Read More
Drug Development Pipeline in Alzheimer’s Disease
KEY TAKEWAYS The Alzheimer’s drug pipeline is rapidly evolving and gaining momentum with a growing, diverse set of 138+ drugs targeting multiple pathways. Key trends include real-world validation of anti-amyloid … Read More
Blood-based Biomarker Testing
KEY TAKEWAYS Blood biomarker tests have reached levels of accuracy on par with more intrusive diagnostic tests for Alzheimer’s disease such as cerebrospinal fluid analysis (CSF) and PET imaging. Blood … Read More
Preclinical Alzheimer’s Disease (PCAD)
KEY TAKEWAYS Pre-clinical Alzheimer’s disease (PCAD) is a condition in which Alzheimer’s disease in the form of abnormal amyloid protein concentrations form in the brain before symptoms of Alzheimer’s disease … Read More
Equity issues for Alzheimer’s disease
KEY TAKEWAYS Significant disparities persist in Alzheimer’s detection, diagnosis, treatment, and monitoring, disproportionately affecting racial/ethnic minorities, women, rural, low socioeconomic groups, and persons with Down Syndrome. Addressing disparities in healthcare … Read More
RealClear Health Op-Ed: Getting Medical Breakthroughs to Patients Faster
The U.S. leads the world in developing biomedical innovations, but it often falls short in delivering them to patients. Unless we fix the breakdowns that keep our healthcare system from … Read More
NEWDIGS Design Lab Clinical Innovators Panel Discussion Recap
On September 11th, NEWDIGS Senior Advisor Tom Hubbard moderated a panel discussion with leaders in innovative Alzheimer’s care. The event was part of a NEWDIGS September Design Lab where a … Read More
Addressing Access Barriers with System Dynamics Modeling: New Team Members Welcome!
Streamlining appropriate, timely, and equitable access to disease-modifying therapies lies at the core of the NEWDIGS Alzheimer’s Disease project. However, impactful and scalable system change is challenging. It will require … Read More
Optimizing Biomedical Health Efficiency: Unlocking the Full Potential of Life Science Innovation Through System Design
Our new analysis is now available open access in Therapeutic Innovation & Regulatory Science: Optimizing Biomedical Health Efficiency: Unlocking the Full Potential of Life Science Innovation Through System DesignAuthors Gigi … Read More
Reengineering Alzheimer’s Disease Management: Executive Brief
The approval of disease-modifying therapies for early, symptomatic Alzheimer’s disease is raising hope for patients and caregivers. And promising new therapeutic and diagnostic capabilities are expected in the next five … Read More